http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2018006773-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
filingDate 2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09080bc46c6a1ada13c86ed482057389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b31555ecb8dbcbc3f86cef1a39d1ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103dca4a17fc8f76ec38e593188684a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae827c369e901fe90549368716d43d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b157a30e4616282c21bb2cffd563b28e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d47199ed3527b4976bd622dd1e79e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70bf184528e5ae329129503203ac0b60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6c2990af2e3e07de6f491b26cf8199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f64c1a6d0114c0ebd0f14a5fa0ef3280
publicationDate 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2018006773-A
titleOfInvention PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRIN, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE.
abstract The present invention relates to pharmaceutical compositions comprising doravirine, tenofovir disoproxil fumarate and lamivudine. These compositions are useful for the treatment of HIV infection. Processes for preparing said pharmaceutical compositions are also described.
priorityDate 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58460047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421985865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621

Total number of triples: 41.